You just read:

Clementia Pharmaceuticals Receives Fast Track Designation for Palovarotene for Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

News provided by

Clementia Pharmaceuticals, Inc.

Dec 01, 2014, 07:30 ET